US clinics marketing unproven and unlicensed adipose-derived autologous stem cell interventions

Research output: Contribution to journalComment/debatepeer-review

16 Scopus citations
Original languageEnglish (US)
Pages (from-to)397-402
Number of pages6
JournalRegenerative Medicine
Volume10
Issue number4
DOIs
StatePublished - May 1 2015

Keywords

  • US FDA
  • adipose-derived mesenchymal stromal cells
  • marketing claims
  • patient safety

Cite this